2020年
1. 杜青青（第一作者）、钱妍（通讯作者）在《Front Mol Biosci》杂志发表论文《Molecular Simulation of Oncostatin M and Receptor (OSM-OSMR) Interaction as a Potential Therapeutic Target for Inflammatory Bowel Disease》，影响因子4.188。
2.钱妍（第一作者）、蒋为薇（通讯作者）在《Archives of Microbiology》杂志发表论文《Artesunate inhibits Staphylococcus aureus biofilm formation
by reducing alpha‑toxin synthesis》，影响因子1.884。
3.冉娅娟（共同第一作者）在《Mediators of Inflammation》杂志发表论文《Clinical Differences between Eosinophilic and Noneosinophilic Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study》，影响因子3.758。
4. 王娜（共同第一作者）在《Thrombosis Research》杂志发表论文《Net clinical benefit of antithrombotic therapy in patients with heart failure and sinus rhythm: A network meta-analysis from 5 clinical trials》，影响因子3.266。
5. 王娜（第一作者）、钱妍（通讯作者）在《Annals of Translational Medicine》杂志发表论文《Comparison of effectiveness and safety of direct oral anticoagulants versus vitamin-k antagonists in elderly patients with atrial fibrillation: a systematic review and cost-effectiveness analysis protocol》，影响因子3.689。
6. 王娜（共同第一作者）、钱妍（通讯作者）在《Frontiers in Pharmacology》杂志发表论文《Anticoagulation quality of warfarin and the role of physician–pharmacist collaborative clinics in the treatment of patients receiving warfarin: a retrospective, observational, single-centre study》，影响因子4.225。
2019年
7. 魏来（第一作者、通讯作者）在《OncoTargets and Therapy》杂志发表论文《Upregulation of microRNA-1270 suppressed human glioblastoma cancer cell proliferation migration and tumorigenesis by acting through WT1》，影响因子3.046。
8. 杜青青（第一作者）、钱妍（通讯作者）在《Journal of Biomolecular Structure and Dynamics》杂志发表论文《Elucidating the Tight-binding Mechanism of Two Oral Anticoagulants to Factor Xa by Using Induced-fit Docking and Molecular Dynamics Simulation》，影响因子3.31。
9. 杜青青（通讯作者）、钱妍（通讯作者）在《Medicine》杂志发表论文《Poor response to rivaroxaban in nephrotic syndrome with acute deep vein thrombosis a case report》，影响因子2.028。
10. 王娜（共同第一作者）在《Cardiovascular Diagnosis and Therapy》杂志发表论文《A network meta-analysis for safety of endothelin receptor antagonists in pulmonary arterial hypertension》，影响因子2.006。
11. 胡帮芹（第一作者）、余娴（通讯作者）在《Clinical Rheumatology》杂志发表论文《Accuracy of neutrophil CD64 expression in diagnosing infection in patients with autoimmune diseases: a meta-analysis》，影响因子2.394。
2018年
12. 王娜（共同第一作者）《Medicine》杂志发表论文《Survival benefits of oral anticoagulants in patients with pulmonary arterial hypertension Protocol for a systematic review and meta-analysis》，影响因子2.028。
2017年
13. 李頔（共同第一作者）《Oncotarget》杂志发表论文《Synergistic antibiotic effect of looped antimicrobial peptide CLP-19 with bactericidal and bacteriostatic agents》，影响因子5.168。
2016年
14. 李頔（共同第一作者）《Biochem Biophys Res Commun》杂志发表论文《Looped limulus anti-lipopolysaccharide derived peptide CLP-19 induces endotoxin tolerance involved inhibition of NF-kB activation》，影响因子2.466。
15. 余娴（第一作者、通讯作者）《Vaccine》杂志发表论文《A DNA vaccine encoding VP22 of herpes simplex virus type I (HSV-1) and OprF confers enhanced protection from Pseudomonas aeruginosa in mice》，影响因子3.413。
16. 余娴（第一作者、通讯作者）《Oncol Rep》杂志发表论文《Herpes simplex virus type 1 VP22-mediated intercellular delivery of PTEN increases the antitumor activity of PTEN in esophageal squamous cell carcinoma cells in vitro and in vivo》，影响因子2.486。
17. 余娴（第一作者、通讯作者）《EXPERIMENTAL AND THERAPEUTIC MEDICINE》杂志发表论文《The expression, purification, and production of antisera against recombinant truncated VP22 protein》，影响因子1.28。
18. 蒋为薇（第一作者）在《Phytomedicine》杂志发表论文《Artesunate attenuated progression of atherosclerosis lesion formationalone or combined with rosuvastatin through inhibition of pro-inflammatory cytokines and pro-inflammatory chemokines》，影响因子3.526
服务热线
服务热线
版权所有: 重庆医科大学附属第二医院 | Copyright @ 2016-2026 CQSAHCQMU.CN All Right Reserved. 渝ICP备15009793号-10 渝公网安备 50010302000990号
技术支持：瑞秀科技
